INTRODUCTION
The majority of patients diagnosed with breast cancer will be long-term survivors of their disease. 1 Despite generally good survival outcomes, however, these patients often develop a number of undesirable symptoms after treatment that tend to occur in a cluster (eg, pain, insomnia, fatigue, mood disorders, and cognitive dysfunction). 2 Experiencing this cluster can have a marked impact on health-related quality of life for these survivors. [3] [4] [5] This symptom cluster can occur at all stages of cancer and can persist for years. 4 Current thinking is that the symptoms within a cluster share a common pathophysiologic origin. [6] [7] [8] In the 2005 National Institute of Medicine report entitled "From Cancer Patient to Cancer Survivor: Lost in Transition," the need to improve management of long-term and late effects in cancer survivors is highlighted. 9 Treatment of this symptom cluster, however, has proven challenging despite multiple clinical trials of pharmacologic and nonpharmacologic approaches. A number of different management options have been recommended in national guidelines. For example, for management of insomnia and fatigue, ASCO recommends nonpharmacologic approaches, including physical activity and cognitive behavioral therapy (CBT). 10 In contrast, for neuropathic pain caused by chemotherapyinduced peripheral neuropathy, ASCO guidelines recommend consideration of treatment with the serotonin and norepinephrine reuptake inhibitor duloxetine. 11 However, because many patients experience multiple symptoms concomitantly, it would be preferable to identify a single intervention capable of covering multiple symptoms.
Patients with fibromyalgia, a chronic pain condition, report a similar constellation of symptoms that includes pain, insomnia, and fatigue. Individuals with fibromyalgia similarly tend to have a poor response to standard analgesic medications; thus, alternative treatment options have been explored. One such example is an Internet-based exercise and behavioral pain management program entitled "Living Well with Fibromyalgia." 12 This program was developed according to CBT principles with the goal of improving this symptom cluster in patients with fibromyalgia. In a randomized trial of 118 patients that compared the intervention with standard care, the investigators found that pain, physical functioning, and overall global improvement were significantly improved in the patients assigned to the intervention. 12 CBT is an extremely effective gold-standard, nonpharmacologic, psychological treatment of numerous chronic conditions, including chronic pain, fatigue, and insomnia. [13] [14] [15] CBT-based approaches help patients learn how to use strategies such as exercise, distraction, and relaxation techniques and how to manage thoughts, beliefs, or expectations that negatively influence symptom severity.
A number of CBT-based interventions have been studied previously for symptom management in breast cancer. For example, traditional in-person CBT has been effective for the treatment of insomnia 16, 17 and fatigue, 18 and to improve quality of life. 19 As technology has advanced and become more integrated into daily life, online CBT interventions have been developed to target specific symptoms for cancer survivors, including insomnia, 20, 21 fatigue, 22 menopausal symptoms, 23 and quality of life. 24 To date, few online interventions have been reported that are designed to enable lifestyle and behavioral self-management. [24] [25] [26] We hypothesized that an approach similar to the fibromyalgia intervention described in this introduction would be effective to reduce the same chronic symptoms when found in patients with breast cancer. We adapted the original fibromyalgia intervention to form the Proactive Self-Management Program for Effects of Cancer Treatment (PROSPECT), which focuses on a cancer-specific population. In its development, we prospectively enrolled patients and tested both the acceptability and the effect of the intervention on patients with breast cancer who had pain, insomnia, and/or fatigue.
PATIENTS AND METHODS

Patient Selection
Women with a history of stage 0 to 3 breast cancer who reported pain, fatigue, or trouble sleeping were potentially eligible to participate. Patients were recruited from the outpatient cancer clinics at a single institution. Patients had to have completed all indicated surgery, radiation therapy, and chemotherapy at least 3 months before enrollment. If endocrine therapy was prescribed, patients had to have initiated treatment at least 3 months before enrollment. Patients could not have a diagnosis of obstructive sleep apnea or restless leg syndrome that was currently interfering with sleep. In addition, patients had to have access to and be able to operate a computer with Internet access and had to be able to read and understand English.
To be eligible, patients had to report one of the following scores or answers: (1) at least 4 of 10 to the question, "How tired did you feel in the past week?"; (2) yes to the question, "Did you have trouble sleeping in the past week?"; or (3) at least 4 of 10 to the question, "What was your average pain in the past week?" If patients reported more than one symptom, they were asked to designate the primary symptom of concern.
The study (ClinicalTrials.gov identifier: NCT02495155) was approved by the University of Michigan institutional review board. All patients provided written informed consent before completion of any study procedures.
Study Intervention
The original "Living Well with Fibromyalgia" CBTbased self-management program 12 was used as the foundation for the development of PROS-PECT, a cancer-specific symptom management intervention. PROSPECT included modules about late effects of therapy, symptom management, and lifestyle change ( Table 1 ; Appendix Fig A1) . Information was presented with both written and video formats, and patients could download worksheets and tip sheets. The Flesch-Kincaid reading grade level of PROSPECT is 7.3. Two introductory modules oriented patients to use of the program: (1) Getting Started, and (2) Steps for Me. On the basis of previously tested methods, patients had unrestricted access to the online program and were instructed to use the PROSPECT resources that were the most relevant to their own needs.
12
Study Procedures
After enrollment, patients completed the National Institutes of Health Patient-Reported Outcomes Measurement Information System (PROMIS)-29 profile, version 2.0, on paper to assess pain intensity and interference, fatigue, sleep disturbance, physical functioning, depression, anxiety, and ability to participate in social roles and activities. Patients then were provided access to the PROSPECT online program for 8 weeks.
Patients were contacted by phone briefly by a research assistant who used a semistructured interview format within 36 hours and again 1, 2, 4, and 6 weeks after the baseline visit to ensure program usage and to address any technological difficulties with use of the site; no symptom management counseling was provided. After 8 weeks, patients were contacted by e-mail and asked to complete follow-up questionnaires online. Patients who did not complete the questionnaire within 1 week of the e-mail received a reminder phone call from the research assistant.
The PROMIS-29 adult profile, which was developed by the NIH roadmap initiative PROMIS, contains eight domains that assess the following symptoms during the previous 7 days: pain intensity (one item), pain interference (four items), fatigue (four items), sleep disturbance (four items), physical functioning (four items), emotional distress-depression (four items), emotional distress-anxiety (four items), and ability to participate in social roles and activities (four items). 27, 28 Pain intensity is reported on a scale from 0 (no pain) to 10 (worst imaginable pain). Scores for each of the other domains are calculated and then converted to a T score, which rescales the raw score into a standardized score that has a mean of 50 and a standard deviation (SD) of 10. Higher T scores represent more of the construct that the item is measuring. Therefore, an increase in T score at the 8-week time point compared with baseline would indicate a worsening of pain severity, pain interference, fatigue, sleep disturbance, depression, and anxiety, and an improvement in physical functioning and ability to participate in social roles and activities. PROMIS instruments have undergone extensive psychometric testing in patients with cancer by using item response theory-based and classic test theory-based methods and have ascopubs.org/journal/cci JCO™ Clinical Cancer Informatics 3 been demonstrably reliable, valid, and responsive. [29] [30] [31] [32] We used the validated, single-item Patient Global Impression of Change (PGIC) questionnaire to evaluate participant impressions of their symptom improvement after study completion. The PGIC uses a 7-point scale that ranges from "very much improved" to "very much worse." 33 Last, an 11-item modified internet intervention utility questionnaire asked about participant impressions of the usability and acceptability of the intervention (adapted from Thorndike et al 34 ), how often they used the modules, and their comfort level with use of a computer. The key questions about whether the intervention was understandable, useful, enjoyable, acceptable to the participant, acceptable to others, and generally effective had excellent internal consistency, reflected by a standardized α ≥ .93.
Statistics
Age was compared between completers versus noncompleters with a Wilcoxon rank sum test that was based on the small numbers and nonnormality of age in the groups. Age was compared between those who experienced a minimal to large change in symptoms versus those who did not and between those who found the intervention at least mostly acceptable versus not via t tests, because there were greater numbers and the normality assumption was met. Frequencies, means, and SDs were calculated for the entire cohort and by initial symptom of interest. The signed rank test compared symptom outcomes from baseline to 8 weeks within each patient because of the non-normal distributions of the differences in outcomes. Effect sizes were calculated according to the methods from Grissom and Kim, 35 because nonparametric tests were used. For negatively worded characteristics, the effect size represented the probability that, in a randomly sampled matched pair of scores, the score from time 2 would be less than the score from time 1, such that the symptom will have improved with time. For the positively worded characteristics of physical function and social roles and activities, the opposite held true. a P value < .05 was considered statistically significant, and multiple comparisons were not controlled because of the small size of the study.
RESULTS
Fifty women with early-stage breast cancer enrolled in the study (Appendix Fig A2) . The mean age of the entire cohort was 58 years ( Table 2 ). In the cohort included in the study, 85% reported use of e-mail and performance of Internet searches daily, and half reported use of Webbased apps. Two thirds of patients had received prior treatment with chemotherapy, and patients had been diagnosed with breast cancer an average of 3.4 years before enrollment. At baseline, patients reported greater-than-population averages of anxiety, fatigue, sleep disturbance, and pain interference. 36 For the entire cohort, mean pain severity was 3.6 (SD, 2.2), and both physical functioning and participation in social activities were below average. Patients were grouped according to primary symptom (ie, fatigue, insomnia, pain); baseline characteristics of each symptom group are listed in Table 2 .
Forty-five patients completed both baseline and week-8 PROMIS assessments. Because of the concern that age could influence use of this Internet-based intervention, we examined associations between patient age, reported use of the intervention, and completion of the study assessments. There was no difference in age between the completers (n = 45) and noncompleters 
Impact of the PROSPECT Intervention on PatientReported Symptoms
Analysis of change in symptoms in the 45 patient completers showed statistically significant improvements in anxiety, sleep, fatigue, activity level, and pain severity ( Table 3 ; Fig 1) . The patients who reported fatigue or insomniabut not those who reported pain-as their primary symptom had statistically significant improvements in the primary symptom between baseline and the 8-week time point (for fatigue: mean, −8.79; SD, 9.9; P = .009; and for insomnia, mean, −4.3; SD, 6.7; P = .019).
In the entire cohort, T scores for sleep and fatigue improved by −4.22 (SD, 11.6; P = .048) and −5.23 (SD, 8.0; P ≤ .001), respectively. The mean reduction in anxiety was 2.01 (SD, 5.5; P = .018), and the mean improvement for activity was 2.79 (SD, 9.4; P = .046). The mean reduction in pain severity was 0.89 (SD, 1.7; P < .001) on a 0-to 10-point scale, from a mean of 3.62 at baseline to 2.66 at the 8-week timepoint.
The intervention was associated with the greatest improvements in symptoms reported by individuals with fatigue as their primary symptom. These individuals noted statistically significant improvements in fatigue, anxiety, pain intensity, pain interference, and participation in social roles and activities ( Table 3) . They did not report improvements in physical function, depression, or sleep disturbance. Only statistically significant improvements in sleep disturbance and fatigue were noted with the 8-week intervention in the group of patients with insomnia as their primary symptom. None of the symptoms significantly improved in the group of patients who reported pain as their primary symptom.
After 8 weeks of treatment with the Web-based intervention, 22 patients (62.9%) reported on the PGIC questionnaire that their primary symptom was minimally (n = 15), much (n = 5), or very much (n = 2) improved, whereas the other 13 patients reported no change (n = 12) or worsening (n = 1) of the primary symptom. There was no difference in improvement in the primary symptom by patient age (mean [SD] age for improved v no change or worsened: 58.2 [9.3] years v 60.3 [10.0] years; P = .54). Five patients discontinued study participation before the 8-week assessment. The remaining 10 patients either reported no use of the intervention (n = 5) or they did not complete the PGIC questionnaire (n = 5).
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Acceptability of the PROSPECT Intervention
Of the 34 patients who completed the utility questionnaire, 85% (29 of 34 patients) reported that the PROSPECT intervention was mostly or very easy to use, 76% (26 of 34 patients) reported that it was mostly or very convenient to use, and 71% (24 of 34 patients) reported that it was mostly or very much acceptable to them. In analysis by patient age, there was no difference in whether patients perceived that the intervention was acceptable to them (mean [SD] age for mostly or very much acceptable v somewhat or less acceptable: 58.9 [10.1] years v 59.3 [8.8] years; P = .91). In addition, 23 patients (67%) would consider use of the intervention, and 21 (62%) would recommend it to others. The modules reported as most helpful were those about sleep, exercise, relaxation, and late effects of therapy.
DISCUSSION
In this pilot study of an Internet-based selfmanagement intervention for cancer survivors, symptomatic patients with breast cancer, especially those with fatigue, reported reductions in multiple symptoms, including anxiety, sleep disturbance, fatigue, and pain severity, after 8 weeks of the intervention. In addition, patients reported increased participation in social activities. These preliminary findings support the use of an Internet-based, nonpharmacologic approach such as this one to target symptom clusters in survivors of breast cancer.
This study complements others previously reported in the literature. CBT has been effective for the management of a number of individual symptoms, including fatigue, insomnia, and endocrine symptoms. 16, 18, 23 However, most previously reported studies have used in-person administration of CBT, typically delivered by a therapist or by another trained personnel. Logistically, it can be challenging for patients who juggle other responsibilities, including work and family, to attend individual or group sessions. It can also be cost prohibitive and/or inaccessible for patients, depending on the socioeconomic situation or place of residence.
The unguided approach used in PROSPECT allows patients to participate in the modules on their own schedules, although it does require 38 Instead, it focuses specifically on providing patients with the tools for behavioral and lifestyle self-management. On the basis of our findings and those of others, a self-guided symptom management approach has the potential to improve multiple symptoms for cancer survivors in an easily deliverable format that can be widely disseminated. In addition, the intervention can be designed so that it is individualized according to the unique needs of a patient.
The intervention seemed to work best for individuals with fatigue as the primary concern and less well for individuals with pain as the primary concern. This finding is curious, given that PROSPECT was based on a pain management intervention that had demonstrated efficacy for pain as well as other symptoms in fibromyalgia. When analysis of data from all patients in the study who reported pain, as opposed to just those who named pain as their primary symptom, is reviewed it seems likely that the small sample size limited our ability to detect an improvement in pain and other symptoms in the pain cohort (unpublished results). Alternatively, during adaptation of the fibromyalgia intervention into PROSPECT, the emphasis on pain may have become diluted. It is also possible that insomnia and fatigue can show improvements in shorter time frames than is needed for an improvement in pain. Finally, the enrolled survivors who reported pain as the primary concern are likely quite heterogeneous, because patients can experience pain from a variety of treatment regimens and with different underlying etiologies that may respond variably to the PROSPECT intervention. In contrast, the pain experienced by patients with fibromyalgia may result from a single underlying mechanism.
Our findings are limited by the small size of the study. Because only approximately 70% of the sample responded to the question about the acceptability of the intervention, the finding that the intervention is acceptable to most participants may have been influenced by response bias. In addition, we did not electronically capture the platform used by the patients or the frequency of use of the intervention, and we relied on patient self-report about which modules were most useful. Therefore, we were unable to capture the effective dose of the intervention that was administered. Finally, because education and ethnicity were not captured, the ability to assess generalizability of our findings to other populations is limited.
Although small, this pilot study provides important information about the potential utility of this Internet-based intervention. Additional larger randomized studies that use an attention-control group are warranted to evaluate the efficacy of the PROSPECT intervention compared with standard symptom management approaches, to identify the optimal dose of the intervention, and to characterize patients most likely to benefit from the intervention. Optimization of patient management ultimately could lead to improved quality of life for breast cancer survivors. 
